180 related articles for article (PubMed ID: 8462452)
1. Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner.
Schwartz Z; Bonewald LF; Caulfield K; Brooks B; Boyan BD
Endocrinology; 1993 Apr; 132(4):1544-52. PubMed ID: 8462452
[TBL] [Abstract][Full Text] [Related]
2. The synergistic effects of vitamin D metabolites and transforming growth factor-beta on costochondral chondrocytes are mediated by increases in protein kinase C activity involving two separate pathways.
Schwartz Z; Sylvia VL; Dean DD; Boyan BD
Endocrinology; 1998 Feb; 139(2):534-45. PubMed ID: 9449622
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 1,25-(OH)2D3- and 24,25-(OH)2D3-dependent stimulation of alkaline phosphatase activity by A23187 suggests a role for calcium in the mechanism of vitamin D regulation of chondrocyte cultures.
Schwartz Z; Langston GG; Swain LD; Boyan BD
J Bone Miner Res; 1991 Jul; 6(7):709-18. PubMed ID: 1659121
[TBL] [Abstract][Full Text] [Related]
4. Direct effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities.
Schwartz Z; Schlader DL; Swain LD; Boyan BD
Endocrinology; 1988 Dec; 123(6):2878-84. PubMed ID: 3264240
[TBL] [Abstract][Full Text] [Related]
5. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles.
Maeda S; Dean DD; Gay I; Schwartz Z; Boyan BD
J Bone Miner Res; 2001 Jul; 16(7):1281-90. PubMed ID: 11450704
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner.
Dean DD; Boyan BD; Muniz OE; Howell DS; Schwartz Z
Calcif Tissue Int; 1996 Aug; 59(2):109-16. PubMed ID: 8687979
[TBL] [Abstract][Full Text] [Related]
7. Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3-responsive phenotype characteristic of growth zone chondrocytes.
Schwartz Z; Dean DD; Walton JK; Brooks BP; Boyan BD
Endocrinology; 1995 Feb; 136(2):402-11. PubMed ID: 7530645
[TBL] [Abstract][Full Text] [Related]
8. Production of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by growth zone and resting zone chondrocytes is dependent on cell maturation and is regulated by hormones and growth factors.
Schwartz Z; Brooks B; Swain L; Del Toro F; Norman A; Boyan B
Endocrinology; 1992 May; 130(5):2495-504. PubMed ID: 1572278
[TBL] [Abstract][Full Text] [Related]
9. Lysophospholipid regulates release and activation of latent TGF-beta1 from chondrocyte extracellular matrix.
Gay I; Schwartz Z; Sylvia VL; Boyan BD
Biochim Biophys Acta; 2004 Aug; 1684(1-3):18-28. PubMed ID: 15450206
[TBL] [Abstract][Full Text] [Related]
10. The effects of vitamin D metabolites on phospholipase A2 activity of growth zone and resting zone cartilage cells in vitro.
Schwartz Z; Boyan B
Endocrinology; 1988 May; 122(5):2191-8. PubMed ID: 3258818
[TBL] [Abstract][Full Text] [Related]
11. Recombinant bone morphogenetic protein (BMP)-2 regulates costochondral growth plate chondrocytes and induces expression of BMP-2 and BMP-4 in a cell maturation-dependent manner.
Erickson DM; Harris SE; Dean DD; Harris MA; Wozney JM; Boyan BD; Schwartz Z
J Orthop Res; 1997 May; 15(3):371-80. PubMed ID: 9246083
[TBL] [Abstract][Full Text] [Related]
12. Regulation of protein kinase C by transforming growth factor beta 1 in rat costochondral chondrocyte cultures.
Sylvia VL; Mackey S; Schwartz Z; Schuman L; Gomez R; Boyan BD
J Bone Miner Res; 1994 Sep; 9(9):1477-87. PubMed ID: 7817833
[TBL] [Abstract][Full Text] [Related]
13. The synergistic effect of TGF beta and 24,25-(OH)2D3 on resting zone chondrocytes is metabolite-specific and mediated by PKC.
Schwartz Z; Sylvia VL; Dean DD; Boyan BD
Connect Tissue Res; 1996; 35(1-4):101-6. PubMed ID: 9084648
[TBL] [Abstract][Full Text] [Related]
14. Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation.
Schwartz Z; Carney DH; Crowther RS; Ryaby JT; Boyan BD
J Cell Physiol; 2005 Feb; 202(2):336-43. PubMed ID: 15534863
[TBL] [Abstract][Full Text] [Related]
15. Treatment of resting zone chondrocytes with transforming growth factor-beta 1 induces differentiation into a phenotype characteristic of growth zone chondrocytes by downregulating responsiveness to 24,25-(OH)2D3 and upregulating responsiveness to 1,25-(OH)2D3.
Schwartz Z; Sylvia VL; Liu Y; Dean DD; Boyan BD
Bone; 1998 Nov; 23(5):465-70. PubMed ID: 9823454
[TBL] [Abstract][Full Text] [Related]
16. The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro.
Boyan BD; Schwartz Z; Carnes DL; Ramirez V
Endocrinology; 1988 Jun; 122(6):2851-60. PubMed ID: 2836176
[TBL] [Abstract][Full Text] [Related]
17. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures.
Sylvia VL; Schwartz Z; Schuman L; Morgan RT; Mackey S; Gomez R; Boyan BD
J Cell Physiol; 1993 Nov; 157(2):271-8. PubMed ID: 8227160
[TBL] [Abstract][Full Text] [Related]
18. The effects of 17 beta-estradiol on chondrocyte differentiation are modulated by vitamin D3 metabolites.
Schwartz Z; Finer Y; Nasatzky E; Soskolne WA; Dean DD; Boyan BD; Ornoy A
Endocrine; 1997 Oct; 7(2):209-18. PubMed ID: 9549047
[TBL] [Abstract][Full Text] [Related]
19. Stathmin levels in growth plate chondrocytes are modulated by vitamin D3 metabolites and transforming growth factor-beta1 and are associated with proliferation.
Hummert TW; Schwartz Z; Sylvia VL; Dean DD; Boyan BD
Endocrine; 2001 Jun; 15(1):93-101. PubMed ID: 11572331
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandins mediate the effects of 1,25-(OH)2D3 and 24,25-(OH)2D3 on growth plate chondrocytes in a metabolite-specific and cell maturation-dependent manner.
Schwartz Z; Gilley RM; Sylvia VL; Dean DD; Boyan BD
Bone; 1999 May; 24(5):475-84. PubMed ID: 10321907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
